SABBY MANAGEMENT, LLC - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 84 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$47,636
-55.8%
65,714
-67.8%
0.04%
-56.8%
Q4 2022$107,799
-68.6%
203,971
-50.5%
0.10%
-78.1%
Q3 2022$343,000
-40.0%
411,896
-21.5%
0.43%
+11.3%
Q2 2022$572,000
+26.3%
524,805
+44.9%
0.39%
+472.1%
Q1 2022$453,000
-93.1%
362,072
-65.4%
0.07%
-92.7%
Q2 2021$6,611,000
+1193.7%
1,045,987
+331.8%
0.93%
+841.4%
Q1 2021$511,000
-0.4%
242,237
-51.8%
0.10%
-12.4%
Q4 2018$513,000
-37.0%
502,448
+8.0%
0.11%
+8.7%
Q3 2018$814,000
+8.5%
465,039
+36.5%
0.10%
-10.3%
Q2 2018$750,000340,7490.12%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 347,392$2560.02%
XTX Topco Ltd 167,427$123,3100.02%
Laurion Capital Management LP 2,225,800$1,639,3020.01%
Virtu Financial LLC 80,728$590.01%
Renaissance Technologies 1,242,370$9150.00%
LVM CAPITAL MANAGEMENT LTD/MI 21,000$150.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,8250.00%
Connor, Clark & Lunn Investment Management Ltd. 133,591$98,3900.00%
Caption Management, LLC 75,000$55,2380.00%
J. L. Bainbridge & Co., Inc. 11,121$8,1910.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders